← All trials
NCT06547333
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 13, 2024
- Primary completion
- Apr 29, 2032
- Completion date
- Oct 31, 2032
- First posted
- Aug 9, 2024
- Last posted
- Aug 14, 2024
- Enrollment
- 884
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shijiazhuang Pharma Group (CSPC)Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.